Cancer Research  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 11, 56-63, January 1, 1951]
© 1951 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Steiner, P. E.
Right arrow Articles by Falk, H. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Steiner, P. E.
Right arrow Articles by Falk, H. L.

Summation and Inhibition Effects of Weak and Strong Carcinogenic Hydrocarbons: 1:2-Benzanthracene, Chrysene, 1:2:5:6-Dibenzanthracene, and 20-Methylcholanthrene*

Paul E. Steiner and Hans L. Falk

(From the Department of Pathology, University of Chicago, Chicago 37, Ill.)

1. 1:2-Benzanthracene and chrysene were carcinogenic, inducing sarcoma on subcutaneous injection. The former was stronger than the latter, having both a shorter induction time and a higher tumor yield. The significance of these results with regard to the relation of chemical-physical characteristics of hydrocarbons to their carcinogenicity is discussed.
2. 1:2-Benzanthracene and chrysene injected together showed definite summation of carcinogenic effects if not actually a synergistic action. The tumor yield was greater than the sum of their individual tumor yields, despite the halving of the dose of each compound injected. This observation is significant, because it cannot be explained by the existing theories of inhibition or summation effects of carcinogenic compounds.
3. The carcinogenic effects of 1:2-benzanthracene and 1:2:5:6-dibenzanthracene injected together were not those of summation but apparently of inhibition.
4. The carcinogenic effects of 1:2:5:6-dibenzanthracene and 20-methylcholanthrene injected together were additive, although imperfectly so.

* This investigation was aided by a research grant from the American Cancer Society, on recommendation by the Committee on Growth of the National Research Council.

Received 8/30/50.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1951 by the American Association for Cancer Research.